Decoy Therapeutics is trading at $5.50 (up 11.8%) in after-hours sessions as it rebounds from recent weakness following its $21 million private placement financing in late June.

  • The move appears driven by thin after-hours liquidity and traders repositioning after a multi-day pullback and post-financing volatility.
  • No new SEC filings, press releases, analyst actions, or clinical updates were identified for the July 21–22 period to serve as a fresh catalyst.